NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR-21.1%
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

3Y CAGR
-21.1%/yr
Annual compound
Percentile
P80
Within normal range
vs 3Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202531.64%
2024-19.07%
2023-80.67%
202264.37%
2021-190.43%
20200.00%